Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

May 7, 2020 Leave a comment 1,800 Views

Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: genomic cancer testing

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

dsRID – in silico identification of dsRNA regions using long-read RNA-seq data

FUN-PROSE – predicting the response of fungal genes

Unraveling the timeline of gene expression – a pseudotemporal trajectory analysis of single-cell RNA sequencing data

INVADEseq – cataloging bacterial diversity within tumor samples

RNA sequencing identifies genetic effects of traumatic brain injury using an artificial brain

Researchers develop new method to identify and remove background noise from single cell data

scReadSim – a single-cell RNA-seq and ATAC-seq read simulator